Table 2. Diagnosis, treatment results .... | American Society of Hematology

Table 2.

Diagnosis, treatment results

			Patients suffering from tumor failure	Site of tumor failure (any involvement^*)
Diagnosis	No. of patients (%)	pEFS, 3 y, %	Patients suffering from tumor failure		Local	BM	CNS	Testes	New site
Burkitt lymphoma	283 (56)	93 ± 2	14	8	6	6	2	5
B-AL	79 (16)	77 ± 5	12	2	9	4	0	2
Diffuse large B-cell lymphoma
Centroblastic	81 (16)	93 ± 3	4	3	0	0	0	2
Immunoblastic	7	NA	1	1	0	0	0	1
T-cell rich B-cell lymphoma	9	NA	1	1	0	0	0	0
Primary mediastinal large B-cell lymphoma	15 (3)	53 ± 13†	7	7	0	0	0	3
B-NHL, not further specified	31 (6)	100	0	0	0	0	0	0
All	505 (100)	89 ± 1	39	22	15	10	2	13

			Patients suffering from tumor failure	Site of tumor failure (any involvement^*)
Diagnosis	No. of patients (%)	pEFS, 3 y, %	Patients suffering from tumor failure		Local	BM	CNS	Testes	New site
Burkitt lymphoma	283 (56)	93 ± 2	14	8	6	6	2	5
B-AL	79 (16)	77 ± 5	12	2	9	4	0	2
Diffuse large B-cell lymphoma
Centroblastic	81 (16)	93 ± 3	4	3	0	0	0	2
Immunoblastic	7	NA	1	1	0	0	0	1
T-cell rich B-cell lymphoma	9	NA	1	1	0	0	0	0
Primary mediastinal large B-cell lymphoma	15 (3)	53 ± 13†	7	7	0	0	0	3
B-NHL, not further specified	31 (6)	100	0	0	0	0	0	0
All	505 (100)	89 ± 1	39	22	15	10	2	13

Note: multiple sites can be involved in one patient.

P < .05 (log-rank test) for all comparisons.